Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 15, 2018 02:40 ET | Source: Active Biotech

NOTICE OF EXTRAORDINARY SHAREHOLDERS' MEETING

The shareholders of Active Biotech AB (publ) are invited to the Extraordinary Shareholders' Meeting to be held on Monday 19 March 2018, at 5 pm at the company's offices, Scheelevägen 22 in Lund,...
February 15, 2018 02:31 ET | Source: Active Biotech

Active Biotech carries out rights issue

Read the press release here ...
February 15, 2018 02:31 ET | Source: Active Biotech

Active Biotech genomför företrädesemission

Läs pressreleasen här ...
February 15, 2018 02:30 ET | Source: Active Biotech

Active Biotech AB Bokslutsrapport januari - december 2017

Kvartal 4 i korthet Det primära kliniska studiemålet uppnåddes inte i fas II studien (ARPEGGIO) med laquinimod i PPMS Patent avseende tasquinimod för behandling av akut leukemi beviljades i...
February 15, 2018 02:30 ET | Source: Active Biotech

Active Biotech AB Year-end report January - December 2017

Fourth quarter in brief The primary clinical endpoint was not met in the Phase II study (ARPEGGIO) with laquinimod in PPMS Patent regarding tasquinimod for the treatment of acute leukemia...
December 20, 2017 09:00 ET | Source: Active Biotech

Active Biotech lämnar uppdaterad information om bolagets finansiella ställning

PRESSMEDDELANDE Active Biotech har erhållit en waiver (undantag) från sitt åtagande gentemot den bank som finansierar bolagets fastighet i Lund att alltid ha en lägsta likviditet av minst 30...
December 20, 2017 09:00 ET | Source: Active Biotech

Active Biotech provides updated information about the company's financial position

PRESS RELEASE Active Biotech has received a waiver (exemption) from its commitment to the bank that finances the company's property in Lund that the company's liquidity should never fall below SEK...
December 07, 2017 13:00 ET | Source: Active Biotech

Active Biotech provides updated information about the company's financial position - the company currently lacks funding to ensure its operations for the coming twelve-month period

PRESS RELEASE Active Biotech (Nasdaq Stockholm: ACTI) provides updated information about the company's financial situation. As informed by the company in the interim report for January-September...
December 07, 2017 13:00 ET | Source: Active Biotech

Active Biotech lämnar uppdaterad information om bolagets finansiella ställning - bolaget har i nuläget inte finansiering för verksamheten för den kommande tolvmånadersperioden

PRESSMEDDELANDE Active Biotech (Nasdaq Stockholm: ACTI) lämnar uppdaterad information om bolagets finansiella situation. Som framgick av bolagets delårsrapport för januari-september 2017 har...
December 01, 2017 07:00 ET | Source: Active Biotech

Active Biotech announce results in ARPEGGIO Phase II trial with laquinimod in Primary Progressive MS

PRESS RELEASE Active Biotech (Nasdaq Stockholm: ACTI) today announced initial results from the Phase II proof of concept study of laquinimod in Primary Progressive MS (PPMS) sponsored by Active...